July 26, 2021, 10:08 AM EDT R&D John Carroll Editor & Founder AbbVie picked up some bonus points earlier this year as one of its pipelines adds from the $63 billion Allergan buyout hit its top-line marks. And now the researchers have produced the detailed data on the case they are making with regulators, with...